Gilead Sciences (NASDAQ:GILD) Given New $105.00 Price Target at Wells Fargo & Company
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective lifted by Wells Fargo & Company from $100.00 to $105.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the company. Needham […]
More Stories
Garde Capital Inc. Takes $34,000 Position in Adobe Inc. (NASDAQ:ADBE)
Garde Capital Inc. acquired a new stake in Adobe Inc. (NASDAQ:ADBE – Free Report) during the first quarter, according to...
PFG Investments LLC Sells 966 Shares of Accenture PLC (NYSE:ACN)
PFG Investments LLC lowered its position in Accenture PLC (NYSE:ACN – Free Report) by 26.6% during the 1st quarter, according...
Garde Capital Inc. Purchases New Shares in United Parcel Service, Inc. (NYSE:UPS)
Garde Capital Inc. purchased a new stake in United Parcel Service, Inc. (NYSE:UPS – Free Report) during the 1st quarter,...
ORG Partners LLC Has $45,000 Stake in Arista Networks, Inc. (NYSE:ANET)
ORG Partners LLC boosted its stake in Arista Networks, Inc. (NYSE:ANET – Free Report) by 43.8% during the 1st quarter,...
Top Entertainment Stocks To Keep An Eye On – June 20th
Arista Networks, Alibaba Group, Warner Bros. Discovery, Walt Disney, SRM Entertainment, Roblox, and BigBear.ai are the seven Entertainment stocks to...
Blue Trust Inc. Grows Stock Holdings in AutoZone, Inc. (NYSE:AZO)
Blue Trust Inc. lifted its position in AutoZone, Inc. (NYSE:AZO – Free Report) by 3.5% during the first quarter, according...